Biothera Names VP Of Biomarker Development
1/27/2014 9:13:36 AM
Peter J. Maimonis, Ph.D. has joined Biothera as Vice President of Biomarker Development and will lead the development and commercialization of assays for the company’s Phase 3 cancer immunotherapy, Imprime PGG®.
Dr. Maimonis previously held several senior positions with various pharmaceutical and diagnostic companies, including Senior Director – Cancer Cell Biology, On-Q-ity; Vice President – Biology R&D, Decision Biomarkers; and Associate Director for Oncology Research, Bayer Health Care.
Help employers find you! Check out all the jobs and post your resume.
comments powered by